About this scholarly article

Lenalidomide and Rituximab for the Initial Treatment of Patients With Chronic Lymphocytic Leukemia: A Multicenter Clinical-Translational Study From the Chronic Lymphocytic Leukemia Research Consortium by James, D. F.; Werner, L.; Brown, J. R.; Wierda, W. G.; Barrientos, J. C.; Castro, J. E.; Greaves, A.; Johnson, A. J.; Rassenti, L. Z.; Rai, K. R.; Neuberg, D.; Kipps, T. J. is a scholarly article available to read on EtoBox.

Author

James, D. F.; Werner, L.; Brown, J. R.; Wierda, W. G.; Barrientos, J. C.; Castro, J. E.; Greaves, A.; Johnson, A. J.; Rassenti, L. Z.; Rai, K. R.; Neuberg, D.; Kipps, T. J.

Publisher

American Society of Clinical Oncology; American Society of Clinical Oncology (ASCO) (ISSN 0732-183X)

Published

2014

Language

EN